USP7 mutations are associated with adverse outcomes in pediatric T cell acute lymphoblastic leukemia and lymphoma. Li J, Yuan Y, Niu FF, Wang Y, et al. Ann Hematol 2025 Sep 22. doi: 10.1007/s00277-025-06582.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li J, Yuan Y, Niu FF, Wang Y, et al. USP7 mutations are associated with adverse outcomes in pediatric T cell acute lymphoblastic leukemia and lymphoma. Ann Hematol 2025 Sep 22. doi: 10.1007/s00277-025-06582.
PMID: 40982000